1. Home
  2. SBCF vs PGEN Comparison

SBCF vs PGEN Comparison

Compare SBCF & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seacoast Banking Corporation of Florida

SBCF

Seacoast Banking Corporation of Florida

HOLD

Current Price

$32.74

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.63

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBCF
PGEN
Founded
1926
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
SBCF
PGEN
Price
$32.74
$6.63
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
★ $36.71
$13.65
AVG Volume (30 Days)
782.2K
★ 4.6M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
★ 2.32%
N/A
EPS Growth
★ 10.56
N/A
EPS
★ 0.84
0.03
Revenue
N/A
★ $230,981,000.00
Revenue This Year
$29.79
$2,365.68
Revenue Next Year
$6.00
$85.75
P/E Ratio
★ $39.05
$228.17
Revenue Growth
N/A
N/A
52 Week Low
$28.69
$3.04
52 Week High
$36.27
$8.98

Technical Indicators

Market Signals
Indicator
SBCF
PGEN
Relative Strength Index (RSI) 50.64 39.73
Support Level $30.84 $6.57
Resistance Level $34.62 $7.44
Average True Range (ATR) 0.54 0.43
MACD 0.15 -0.17
Stochastic Oscillator 82.32 14.55

Price Performance

Historical Comparison
SBCF
PGEN

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: